《癌癥趨勢(shì)》是《趨勢(shì)評(píng)論》雜志的新成員，提供簡(jiǎn)潔、引人入勝的專家評(píng)論文章，討論癌癥發(fā)現(xiàn)和醫(yī)學(xué)領(lǐng)域快速變化的前沿研究主題和前沿進(jìn)展。該雜志為多學(xué)科信息、討論和教育提供了一個(gè)獨(dú)特的平臺(tái)，這對(duì)科學(xué)家、臨床醫(yī)生、決策者以及患者和倡導(dǎo)者都是有價(jià)值的。最新的機(jī)會(huì)，挑戰(zhàn)和潛在影響的基礎(chǔ)，轉(zhuǎn)化和臨床研究結(jié)果，行業(yè)研發(fā)，技術(shù)和創(chuàng)新，倫理，或癌癥政策和資金平等地提出和辯論在一個(gè)權(quán)威的，但讀者友好的格式。該雜志將涵蓋的關(guān)鍵問題包括:成人和兒童癌癥;個(gè)性化醫(yī)學(xué);腫瘤微環(huán)境、耐藥性與轉(zhuǎn)移;免疫治療;新陳代謝;遺傳學(xué)和表觀遺傳學(xué);診斷、生物標(biāo)記和治療;流行病學(xué)和癌癥預(yù)防;與癌癥有關(guān)的倫理、政策和資金倡議。

Trends in Cancer is a new member of the Trends review journals, offering concise and engaging expert commentary articles that address key frontline research topics and cutting-edge advances in the rapidly changing field of cancer discovery and medicine. The journal provides a unique platform for multidisciplinary information, discussion and education that is valuable for scientists, clinicians, and policy makers, as well as patients & advocates. The latest opportunities, challenges and potential impact of basic, translational and clinical findings, industry R&D, technology and innovation, ethics, or cancer policy and funding are equally presented and debated in an authoritative but reader-friendly format. Critical issues to be covered in the journal include: Adult and Pediatric Cancers; Personalized Medicine; Tumor Microenvironment, Resistance and Metastasis; Immunotherapy; Metabolism; Genetics and Epigenetics; Diagnostics, Biomarkers and Treatment; Epidemiology and Cancer Prevention; Cancer related Ethics, Policy and Funding Initiatives.